Pulmonary Nocardiosis as an Opportunistic Infection in COVID-19
  • Marc Laplace
    Department of Infectious Diseases, Hôpitaux Civils de Colmar, Colmar, France
  • Thomas Flamand
    Department of Infectious Diseases, Hôpitaux Civils de Colmar, Colmar, France
  • Ciprian Ion
    Department of Infectious Diseases, Hôpitaux Civils de Colmar, Colmar, France
  • Simon Gravier
    Department of Infectious Diseases, Hôpitaux Civils de Colmar, Colmar, France
  • Mahsa Mohseni-Zadeh
    Department of Infectious Diseases, Hôpitaux Civils de Colmar, Colmar, France
  • Dominique Debriel
    Department of Microbiology, Hôpitaux Civils de Colmar, Colmar, France
  • Olivier Augereau
    Department of Microbiology, Hôpitaux Civils de Colmar, Colmar, France
  • Guillaume Gregorowicz
    Department of Microbiology, Hôpitaux Civils de Colmar, Colmar, France
  • Martin Martinot
    Department of Infectious Diseases, Hôpitaux Civils de Colmar, Colmar, France

Keywords

Nocardia cyariacigerogica, nocardiosis, COVID-19, SARS-CoV-2, opportunistic infection

Abstract

Secondary bacterial pneumonia infection is frequent in COVID-19 patients. Nocardia are responsible for opportunistic pulmonary infections especially after steroid treatment. We describe a case of pulmonary nocardiosis following critical COVID-19 pneumonia in an 83-year-old male. Two weeks after initiation of dexamethasone 6 mg/L, the patient developed a new episode of acute dyspnea. The sputum cultures identified Nocardia cyriacigeorgica. In spite of intravenous imipenem and cotrimoxazole treatment the patient died. Physicians should be aware of the possibility of nocardiosis in case of deterioration of respiratory status of severe COVID-19 inpatients and perform Nocardia evaluation. This evaluation requires prolonged culture. 

VIEW THE ENTIRE ARTICLE

References

  • Chong WH, Saha BK, Ananthakrishnan R, Chopra A. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia. Infection 2021;49(4):591-605. doi:10.1007/s15010-021-01602-z.
  • Atemnkeng F, Ducey J, Khalil A, Elemam A, Diaz K. Diagnosing disseminated nocardiosis in a patient with COVID-19 pneumonia. J Med Cases 2021;12(8):319-24. doi:10.14740/jmc3716.
  • Colaneri M, Lupi M, Sachs M, Ludovisi S, Di Matteo A, Pagnucco L et al. A challenging case of SARS-CoV-2- AIDS and Nocardiosis coinfection from the S. Matteo COVID-19 REgistry (SMACORE). New Microbiol 2021;44(2):129-34.
  • Arif M, Talon A, Sarma H, Munoz J, Charley E. Nocardia after COVID-19 infection. Chest 2021;160(4):A429. doi:https://doi.org/10.1016/j.chest.2021.07.424.
  • Driscoll S, Carroll WD, Nichani S, Fishwick R, Bakewell K, Gilchrist FJ. COVID-19 infection and nocardiosis causing the death of an adolescent with cystic fibrosis. Pediatr Pulmonol 2022. doi:10.1002/ppul.25954.
  • Duggal SD, Chugh TD. Nocardiosis: a neglected disease. Med Princ Pract 2020;29(6):514-23. doi:10.1159/000508717.
  • Martinez-Barricarte R. Isolated nocardiosis, an unrecognized primary immunodeficiency? Front Immunol 2020;11:590239. doi:10.3389/fimmu.2020.590239.
  • Views: 658
    HTML downloads: 74
    PDF downloads: 306


    Published: 2022-08-22
    Issue: 2022: Vol 9 No 8 (view)


    How to cite:
    1.
    Laplace M, Flamand T, Ion C, Gravier S, Mohseni-Zadeh M, Debriel D, Augereau O, Gregorowicz G, Martinot M. Pulmonary Nocardiosis as an Opportunistic Infection in COVID-19. EJCRIM 2022;9 doi:10.12890/2022_003477.

    Most read articles by the same author(s)